Blog Posts

Why Protocol Complexity Is Slowing First Patient In – And How Small Sponsors Can Fix Start-Up Inefficiencies

By Jessica Cordes - July 23, 2026

Guest Column | July 23, 2026 Why Protocol Complexity Is Slowing First Patient In - And How Small Sponsors Can Fix Start-Up Inefficiencies By Jessica Cordes, senior consultant, Clinical Excellence GmbH Clinical trial start-up inefficiencies are rarely caused by a

Clinical Leader

Extended GCP Training Is A “Must” For Cell And Gene Therapy Clinical Trials

Clinical Leader

These 3 Areas Need Risk Management Attention Now

Clinical Leader

Umbrella? Basket? Discover 4 Types of Adaptive Clinical Trials And Their Benefits

Clinical Leader

How To Determine Country Feasibility For Cell And Gene Therapy Clinical Trials

Clinical Leader

Site Feasibility Tips For Cell And Gene Therapy Clinical Trials

I'm Jessica Cordes

I am a professional in Clinical Operations dedicated to helping you as a small Company

to conduct successful First-In-Human Clinical Trials and develop your Organization to abhiebe your Drug Development Goals.

With a Master's degree in Molecular Life Science and over 15 years of experience in Clinical Trials, whereas over 12 years in Oncology and

over 6 years in Cell and Gene Therapy, I have honed my skills in areas such as

Protocol Design, Site Selection and Site Feasibility, Patient Recruitment, as well as

Organizational Development and Leadership.

Why Protocol Complexity Is Slowing First Patient In – And How Small Sponsors Can Fix Start-Up Inefficiencies

23.07.2026

Clinical Leader

Aligning AI Use Clinical Trials With FDA And EMA Expectations

07.05.2026

Let's Connect

Book a Meeting

Elevate Your Clinical Excellence!

Unlock the power of spotlighted information delivery

via my bi-weekly newsletter Clinical Operations Spotlight